Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2000

View Archived Issues

Ares-Serono advances global R&D program during 1999

Bristol-Myers Squibb reaches significant milestones during 1999

Celltech Chiroscience and Medeva finalize merger

FDA approves new labeling for Hyalgan

Taisho and Takeda to collaborate internationally

Immunomedics reports clinical findings for cancer therapeutic

New formulation of Xatral receives European approvals

Avant and WRAIR to collaborate on HIV vaccine development

Newly issued U.S. patent protects Inhale's dry powder DNA formulations

Immunomedics issued new patent for radioimmunodetection and radioimmunotherapy applications

Beclomethasone Clickhaler approved in France

Carbapenems substituted at the 2-position active against resistant Gram-positive bacteria

Analgesic 1,4-substituted cyclohexyl compounds in development at AstraZeneca

ReVele effectively detects GRP-positive tumors in phase II trial

Licensing opportunity from NIH: 5-lipoxygenase inhibitors as anticancer agents

Neuropharmacological profile of NRA-0160, a unique antipsychotic drug candidate

MCC-134 activates or inhibits K(ATP) channel currrents in a SUR subtype-dependent manner

OPERA will evaluate morbidity and mortality benefits of omapatrilat in at-risk patients

OPC-14523 selected for clinical development as potential antidepressant

Pharmacia selected as name for new company formed by P&U-Monsanto merger

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

American Biogenetic Sciences licenses worldwide rights for ABS-103 to Abbott

Two new anticancer human MAbs enter development at AVI BioPharma

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Studies at DuPont suggest clinical utility of SF-303 and SK-549 as novel antithrombotics

SciClone initiates phase II study of Zadaxin in hepatitis B

Gene-based osteoarthritis collaboration initiated by Quark and Shionogi

Commencement of clinical trials of Altropane for ADHD diagnosis imminent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...